Why is Trident Texofab falling/rising?

As of 02-Sep, Trident Texofab Ltd's stock is currently priced at Rs 249.60, reflecting a decrease of Rs 1.7 or 0.68%. The stock has underperformed its sector by 0.52% today and has experienced a consecutive decline over the last two days, resulting in a total drop of 1.3%. Despite this recent downturn, the stock has shown strong performance over the longer term, with a remarkable 455.28% increase over the past year and a 48.39% rise year-to-date. The company has reported positive results for the last three consecutive quarters, with net sales growth of 24.20% and the highest operating profit to net sales ratio at 7.37%, which indicates solid financial health and may support future price recovery.
In the broader market context, Trident Texofab's short-term performance contrasts with the benchmark Sensex, which has declined by 0.78% over the past week. The stock's recent price movement may be influenced by its current trading position, as it is still close to its 52-week high, just 3.77% away. Additionally, rising investor participation, evidenced by a significant increase in delivery volume, suggests ongoing interest in the stock despite the recent price drop. Overall, while the stock is facing short-term challenges, its long-term performance remains strong, indicating potential resilience in the face of market fluctuations.